Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz
Gewählte Publikation:
SHR Neuro Krebs Kardio Lipid Stoffw Microb
Cvirn, G; Gallistl, S; Koestenberger, M; Baier, K; Fritsch, P; Greilberger, J; Jürgens, G; Muntean, W.
The anticoagulant action of recombinant human activated protein C (rhAPC, Drotrecogin alpha activated): comparison between cord and adult plasma.
THROMB HAEMOST. 2004; 91(5): 912-918.
Doi: 10.1267/THRO04050912
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
- Führende Autor*innen der Med Uni Graz
- Cvirn Gerhard
- Co-Autor*innen der Med Uni Graz
- Fritsch Peter
- Gallistl Siegfried
- Greilberger Joachim
- Jürgens Günther
- Koestenberger Martin
- Muntean Eugen
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
- The present study was performed to compare the anti-coagulant efficiency of recombinant human activated protein C (rhAPC) in cord with that in adult plasma. RhAPC is a promising candidate to improve the outcome of severe sepsis. However, different anticoagulant efficiency of rhAPC in cord compared with adult plasma has to be expected due to physiological low plasma levels of tissue factor pathway inhibitor (TFPI) and antithrombin (AT) present in neonates, two inhibitors known to markedly influence the anticoagulant action of APC. Clot formation was induced in our experiments by addition of high (30 micro M) or low (20 pM) amounts of lipidated tissue factor (TF). High amounts of TF are conventionally applied in standard clotting assays, whereas plasma activation with low amounts of TF probably better matches the conditions in vivo. We demonstrate that under low coagulant challenge increasing amounts of rhAPC (0.1-0.5 micro g/ml final plasma concentration) dose-dependently prolonged clotting time and suppressed thrombin potential and prothrombin fragment 1+2 generation in both cord and adult plasma. The same was true for experiments performed under high coagulant challenge when 4-16 micro g/ml of rhAPC were added. Whereby, cord plasma was significantly more susceptible to addition of rhAPC in the presence of high amounts of TF and adult plasma was significantly more susceptible to addition of rhAPC in the presence of low amounts of TF. We demonstrate that increased anticoagulant efficiency of rhAPC in adult plasma under low coagulant challenge is attributable to the physiological high levels of TFPI and AT present in adults.
- Find related publications in this database (using NLM MeSH Indexing)
- Adult -
- Anticoagulants - pharmacology
- Antithrombin III - analysis
- Blood Coagulation - drug effects
- Blood Coagulation Tests - drug effects
- Dose-Response Relationship, Drug - drug effects
- Fetal Blood - drug effects
- Humans - drug effects
- Infant, Newborn - drug effects
- Lipoproteins - blood
- Protein C - pharmacology
- Recombinant Proteins - pharmacology
- Thromboplastin - pharmacology
- Find related publications in this database (Keywords)
- recombinant human activated protein C
- tissue factor pathway inhibitor
- antithrombin
- tissue factor
- thrombin potential
- cord and adult plasma